Sofinnova Partners is a leading European venture capital firm specializing in life sciences, focusing on healthcare and sustainability. Established in 1972, the firm has over 50 years of experience and has backed more than 500 companies, creating market leaders globally. With over €4 billion in assets under management, Sofinnova Partners is active across the entire value chain of life sciences investments, from seed to later-stage, and partners closely with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential to positively impact the firm's collective future.

The firm's investment strategies include Sofinnova Capital, Sofinnova MD Start, Sofinnova Crossover, Sofinnova Industrial Biotech, Sofinnova Telethon, Sofinnova Digital Medicine, and Sofinnova Biovelocita.